Note 4 - Related Party Transactions

12 Months Ended

Dec. 31, 2017

Notes to Financial Statements

Related Party Transactions Disclosure [Text Block]

4. Related party transactions

In addition to transactions disclosed elsewhere in the consolidated financial statements, the related party transactions for the years presented were as follows:

Dr. Lan Huang

Dr. Lan Huang provided consulting services to BeyondSpring US at a fee of

$300,

$75

and

nil

for the years ended

December 31, 2015,

2016

and

2017,

respectively.

Wanchun Biotech as a noncontrolling shareholder

On

November 28, 2016

and

January 13, 2017,

Wanchunbulin entered into purchase contracts with Wanchun Biotech to purchase drugs from Wanchun Biotech for clinical research purpose. During the years ended

December 31, 2016

and

2017,

Wanchun Biotech purchased drugs amounting to

$110

(

RMB754

) and

$547

(

RMB3,770

) from

third

party vendors and sold to Wanchunbulin without any margin, respectively.

Due to related parties consisted of the following:

	December 31,
	2016		2017
Due to Dr. Lan Huang		210		-